Amneal Pharmaceuticals, Inc. (AMRX)
17.48
-0.06
(-0.34%)
USD |
NASDAQ |
Aug 31, 16:00
17.48
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash from Operations (Annual) : 339.99M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 339.99M |
| December 31, 2024 | 295.03M |
| December 31, 2023 | 183.16M |
| December 31, 2022 | 63.44M |
| December 31, 2021 | 241.82M |
| December 31, 2020 | 379.00M |
| December 31, 2019 | 1.705M |
| December 31, 2018 | 250.23M |
| December 31, 2017 | 234.19M |
| December 31, 2016 | 74.60M |
| December 31, 2015 | 71.93M |
| December 31, 2014 | 32.82M |
| December 31, 2013 | 149.94M |
| December 31, 2012 | 106.21M |
| Date | Value |
|---|---|
| December 31, 2011 | 6.358M |
| December 31, 2010 | 249.76M |
| December 31, 2009 | -8.157M |
| December 31, 2008 | 64.56M |
| December 31, 2007 | 119.01M |
| December 31, 2006 | -5.76M |
| December 31, 2005 | 21.15M |
| December 31, 2004 | |
| December 31, 2003 | -19.22M |
| December 31, 2002 | -15.20M |
| December 31, 2001 | -17.88M |
| December 31, 2000 | -16.00M |
| December 31, 1999 | -6.737M |
| December 31, 1998 | -4.522M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Liquidia Corp. | -35.69M |
| Eli Lilly & Co. | 16.81B |
| Viatris, Inc. | 2.316B |
| Pfizer Inc. | 11.70B |
| Indivior Pharmaceuticals, Inc. | -27.00M |